Issekutz Andrew C, Quinn Patrick J, Lang Bianca, Ramsey Suzanne, Huber Adam M, Rowter Derek, Karkada Mohan, Issekutz Thomas B
Dalhousie University, Halifax, Nova Scotia, Canada.
Arthritis Rheum. 2011 Nov;63(11):3467-76. doi: 10.1002/art.30521.
To investigate P- and E-selectin ligand coexpression with chemokine receptors (CKRs) on T cells in the synovial fluid (SF) and blood of children with juvenile idiopathic arthritis (JIA).
Sixteen patients with polyarticular or persistent oligoarticular JIA (ages 5.3-15.1 years) were studied. SF and venous blood were collected, and immunostaining for the expression of CCR4, CCR5, CXCR3, and P- or E-selectin ligands was performed.
Compared to blood, SF was greatly enriched for CD4+ T cells bearing CCR5, CCR4, CXCR3, and both P- and E-selectin ligand. Twenty-five percent of the CD4+ T cells in SF expressed both CCR5 and CCR4, some also coexpressing CXCR3. Such cells were rare in blood. Half of the few CCR5+ T cells in blood coexpressed P- or E-selectin ligand, a phenotype that was enriched up to 50-fold in SF. A minority of CCR4+ and CXCR3+ cells in blood (∼25%) coexpressed selectin ligand; these were enriched 4-8-fold in SF. Most CCR4-expressing CD4+ T cells expressed both E-selectin ligand and cutaneous lymphocyte antigen.
CCR4-, CCR5-, CXCR3-, and selectin ligand-expressing CD4+ T cells preferentially accumulate in the joints of children with JIA. The marked enrichment of CCR5+ T cells coexpressing P-selectin and/or E-selectin ligand in CD4+ SF T cells suggests that the few such cells in blood selectively migrate to inflamed joints via endothelial P- and E-selectin- and CCR5-activating chemokines. The predominance of CCR4-expressing CD4+ T cells coexpressing E-selectin ligand suggests that such cells migrate not only to areas of cutaneous inflammation, as previously reported, but also to the joints in JIA. Combined targeting of CCR5- and E-selectin-dependent mechanisms may be a relevant treatment strategy.
研究幼年特发性关节炎(JIA)患儿滑液(SF)和血液中T细胞上P-选择素和E-选择素配体与趋化因子受体(CKRs)的共表达情况。
对16例多关节型或持续性少关节型JIA患儿(年龄5.3 - 15.1岁)进行研究。采集滑液和静脉血,对CCR4、CCR5、CXCR3以及P-或E-选择素配体的表达进行免疫染色。
与血液相比,滑液中携带CCR5、CCR4、CXCR3以及P-和E-选择素配体的CD4⁺ T细胞显著富集。滑液中25%的CD4⁺ T细胞同时表达CCR5和CCR4,部分还共表达CXCR3。此类细胞在血液中罕见。血液中少数CCR5⁺ T细胞中有一半共表达P-或E-选择素配体,该表型在滑液中富集高达50倍。血液中少数CCR4⁺和CXCR3⁺细胞(约25%)共表达选择素配体;这些细胞在滑液中富集4 - 8倍。大多数表达CCR4的CD4⁺ T细胞同时表达E-选择素配体和皮肤淋巴细胞抗原。
表达CCR4、CCR5、CXCR3和选择素配体的CD4⁺ T细胞优先在JIA患儿的关节中积聚。CD4⁺滑液T细胞中同时表达P-选择素和/或E-选择素配体的CCR5⁺ T细胞显著富集,提示血液中少数此类细胞通过内皮P-和E-选择素以及激活CCR5的趋化因子选择性迁移至炎症关节。表达CCR4的CD4⁺ T细胞同时表达E-选择素配体占优势,提示此类细胞不仅如先前报道的那样迁移至皮肤炎症区域,还迁移至JIA的关节。联合靶向CCR5和E-选择素依赖机制可能是一种有效的治疗策略。